Department of Urology, Kidney and Urology Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China.
Department of Rehabilitation Medicine, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China.
Cell Death Dis. 2022 May 7;13(5):443. doi: 10.1038/s41419-022-04863-0.
Metabolic dysfunction is seen in cancer cells where increased glycolysis provides energy for growth. Circular RNAs (circRNAs) are thought to assist in glucose metabolism and the switch to glycolysis. Through screening, we found that circVAMP3 was necessary for both glycolytic and proliferative activities in renal cell carcinoma (RCC). Furthermore, circVAMP3 expression was elevated in RCC patients in correspondence with TNM stage. Mechanistically, circVAMP3 was observed to interact directly with lactate dehydrogenase A (LDHA) and modulate its activity. The circVAMP3-LDHA interaction facilitated LDHA phosphorylation at tyrosine 10 (Y10) catalyzed by the upstream kinase fibroblast growth factor receptor type 1 (FGFR1). Therefore, this study reveals a novel molecular mechanism by which circVAMP3 promotes glycolysis and proliferation through regulating the enzymatic activity of glycolytic enzyme, suggesting that circVAMP3 may represent an RCC biomarker and treatment target.
代谢功能障碍可见于癌细胞中,其中增加的糖酵解为生长提供能量。环状 RNA (circRNAs) 被认为有助于葡萄糖代谢和糖酵解的转变。通过筛选,我们发现 circVAMP3 对于肾细胞癌 (RCC) 的糖酵解和增殖活性都是必需的。此外,circVAMP3 的表达在与 TNM 分期相对应的 RCC 患者中升高。从机制上讲,circVAMP3 被观察到与乳酸脱氢酶 A (LDHA) 直接相互作用并调节其活性。circVAMP3-LDHA 相互作用促进了上游激酶成纤维细胞生长因子受体 1 (FGFR1) 催化的 LDHA 在酪氨酸 10 (Y10) 处的磷酸化。因此,本研究揭示了一种通过调节糖酵解酶的酶活性促进糖酵解和增殖的新型分子机制,表明 circVAMP3 可能代表 RCC 的生物标志物和治疗靶点。